BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.
Patients of 18 years or older, with highly suspected glioblastoma on neuro-imagery
Planned surgical tumor resection,
No objection to participate in research
Signed genetic consent
Patients under guardianship, curatorship or protective supervision
Taking immunosuppressants
Pregnant or breast-feeding women
Patients deprived of their liberty by judicial or administrative decision, or under psychiatric care
University Hospital, Bordeaux
Lead sponsor
University of Bordeaux
Collaborator